Titlebook: Serological Cancer Markers; Stewart Sell Book 1992 Springer Science+Business Media New York 1992 antigen.breast cancer.cancer.carcinoma.ce

JIBE

Emilio Bombardieri,Massimo Gionrende der Fachrichtungen Informatik, Maschinenbau, Elektrotechnik undMechatronik. Ebenso ist das Buch eine Hilfe für Ingenieure und Wissenschaftler, die ein Kalman-Filter z. B. für die Datenfusion oder die Sch?tzung unbekannter Gr??en in Echtzeitanwendungen einsetzen m?chten..

意外的成功

Fredrick J. Montzichkeiten. Um jedoch Umwandlungsw?rmen von Substanzproben, wie zum Beispiel Eiwei? in Wasser, zu messen, ist eine sehr hohe Empfindlichkeit notwendig. Man mu? deshalb die hohe W?rmeaufnahme des in der Probe enthaltenen Wassers mit Hilfe der Zwillingsanordnung (s. Abb. 1) durch eine gleich gro?e Wass

黃油沒有

前奏曲

CUR

Cancer Markers of the 1990s,ll enough to be removed surgically. if this had been possible using a simple serum marker assay, many patients otherwise doomed to die of their cancer, could be cured. Unfortunately, for most cancers, if a malignant tumor cannot be removed surgically, other forms of therapy, though often effective,

sed-rate

Alpha-Fetoprotein in the 1990s,tinal origin. The high sensitivity as well as the high specificity of AFP among other cancer markers was established by Abelev et al. (1963) and Tatarinov (1963, 1964), using an immunodiffusion technique by their evolutional discovery of an oncofetal nature of AFP. Following the development of sensi

尊嚴

Carcinoembryonic Antigen,nsists of a single polypeptide chain, containing a 107 amino acid NH-terminal domain and three highly homologous domains of 178 amino acids each (Beauchemin et al., 1987; Oikawa et al., 1987a). The C-terminal domain consists of 26 amino acids and is strongly hydrophobic, providing a potential attach

大門在匯總

lobster

Enzyme Markers,ltered metabolism. Certain enzyme activities may be increased or decreased, or different forms (isozymes) of an enzyme may occur in the tumor. Some of these isozymes may be related to forms normally found in the fetus or placenta (oncodevelopmental forms), or occurring in nonmalignant tissues of the

disrupt